Alison Mather has been named as one of 50 female leaders in healthcare business in the UK.

Produced by BioBeat, 50 Movers and Shakers in BioBusiness 2018 emphasises the current role of women in leading, inspiring and innovating to ensure new technologies and treatments continue to improve UK research, health and society.

Alison was recognised as a rising star for developing revolutionary bioscience products for healthcare

BioBeat Founder Miranda Weston-Smith comments: “Congratulations to the outstanding women leaders who are recognised as the 50 Movers and Shakers in BioBusiness 2018. They are changing what is possible for the benefit of humanity and helping to build a more inclusive, responsive healthcare ecosystem – whether that’s by developing revolutionary products, shaping bioscience through investment, accelerating the innovation pipeline, transforming patient access to healthcare or supporting innovation from concept to market.”

Alison’s research uses whole genome sequencing to identify the contributions of humans, animals, food and the environment to the rise of antimicrobial resistance and the spread of bacterial pathogens. Her One Health approach is providing insights and novel tools to understand these issues at an ecosystem level, which are being incorporated by governmental organisations into how surveillance data are analysed and the development of public health strategies. Alison concurrently holds a Food Standards Agency fellowship and was previously a BBSRC Anniversary Future Leader Fellow.

Jane Osbourn, Vice-President Research and Development at MedImmune, which supported the report, comments: “On behalf of the numerous partners and supporters of the 50 Movers and Shakers in BioBusiness 2018 report, we are delighted to celebrate the achievements of this group of talented women. We hope shining a spotlight on these female leaders will support them to forge stronger networks and realise new opportunities to improve patient health.“

A collaborative innovation platform for healthcare entrepreneurs and leaders, BioBeat has celebrated 50 Movers and Shakers in BioBusiness each year since 2014. It champions collaboration by bringing together scientific and business expertise, and creating a forum for investors and entrepreneurs to partner, which ultimately brings benefits to patients in the form of innovative new treatments. The full report for 2018 is available to download